|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7240 EUR | +0.14% |
|
-1.76% | -24.58% |
Company Valuation: Transgene
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 247.8 | 164.8 | 137.8 | 89.75 | 262.9 | 198 | - | - |
| Change | - | -33.52% | -16.38% | -34.86% | 192.89% | -24.67% | - | - |
| Enterprise Value (EV) 1 | 214.9 | 151.4 | 139.4 | 83.48 | 153.1 | 128.8 | 190.3 | 216.6 |
| Change | - | -29.53% | -7.95% | -40.12% | 83.37% | -15.85% | 47.74% | 13.82% |
| P/E | -12.1x | -5.02x | -6.23x | -2.34x | -3.69x | -5.16x | -3.29x | -8.03x |
| PBR | 3.69x | 4.38x | 8.82x | 5.92x | 1.14x | 2.41x | 9.04x | -72.3x |
| PEG | - | -0.1x | 0.2x | -0.1x | 0.4x | 0.1x | -0.1x | 0.1x |
| Capitalization / Revenue | 14.2x | 15.9x | 17.4x | 14.1x | 36.5x | 27.5x | 27.5x | 3.46x |
| EV / Revenue | 12.3x | 14.6x | 17.6x | 13.1x | 21.2x | 17.9x | 26.4x | 3.79x |
| EV / EBITDA | -10.2x | -5.37x | -4.9x | -2.43x | -4.54x | -2.95x | -2.71x | -9.18x |
| EV / EBIT | -9.14x | -5.06x | -4.64x | -2.34x | -4.37x | -2.91x | -2.69x | -7.39x |
| EV / FCF | -6.59x | -6.94x | -1,408x | -3.12x | -1.07x | -3.24x | -3.15x | -8.63x |
| FCF Yield | -15.2% | -14.4% | -0.07% | -32% | -93.4% | -30.8% | -31.7% | -11.6% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.21 | -0.33 | -0.22 | -0.29 | -0.26 | -0.14 | -0.22 | -0.09 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 17.41 | 10.34 | 7.9 | 6.353 | 7.21 | 7.2 | 7.2 | 57.2 |
| EBITDA 1 | -21 | -28.22 | -28.48 | -34.38 | -33.73 | -43.6 | -70.1 | -23.6 |
| EBIT 1 | -23.52 | -29.9 | -30.05 | -35.66 | -35.06 | -44.3 | -70.8 | -29.3 |
| Net income 1 | -19.54 | -32.8 | -22.33 | -33.97 | -37.52 | -38.2 | -61.6 | -25.3 |
| Net Debt 1 | -32.93 | -13.31 | 1.629 | -6.274 | -109.8 | -69.2 | -7.7 | 18.6 |
| Reference price 2 | 2.5400 | 1.6580 | 1.3700 | 0.6800 | 0.9600 | 0.7230 | 0.7230 | 0.7230 |
| Nbr of stocks (in thousands) | 97,576 | 99,370 | 100,566 | 131,990 | 273,827 | 273,882 | - | - |
| Announcement Date | 16/03/22 | 16/03/23 | 27/03/24 | 27/03/25 | 24/03/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.16x | 17.89x | -2.95x | - | 225M | ||
| 21.08x | 6.49x | 14.2x | 1.51% | 55.92B | ||
| 33.57x | 8.33x | 25.41x | 0.06% | 56.67B | ||
| -18.45x | 4.44x | -7.77x | -.--% | 23.28B | ||
| -42.05x | 13.36x | -39.35x | -.--% | 23.28B | ||
| 25.7x | 5.07x | 13.38x | -.--% | 20.54B | ||
| 24.87x | 4.83x | 15.68x | -.--% | 17.78B | ||
| -617.89x | 37.85x | -1571.42x | -.--% | 15.9B | ||
| 44.16x | 17.85x | 45.97x | 0.08% | 14.64B | ||
| 17.51x | 5.07x | 11.83x | -.--% | 13.99B | ||
| Average | -51.67x | 12.12x | -149.50x | 0.18% | 24.22B | |
| Weighted average by Cap. | -25.97x | 9.81x | -92.70x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- TNG Stock
- Valuation Transgene
Select your edition
All financial news and data tailored to specific country editions
















